NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
MD ANDERSON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MD ANDERSON
ST13
US500000098480259Class
35, 44, 45
Filing
98480259
Registration
7896459
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
08/19/2025
Classification
Registered
Trademark type
Word
Nice classes
35, 44, 45
Filing date
04/02/2024
Registration date
08/19/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/1942
First use in commerce
01/01/1942
Drawing code
4
Owner type
99
Owner location
Austin, TX, US
Examiner
LAWRENCE, SUSAN KASTRINER
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
The Board of Regents of the University of Texas System
Representatives
Robin Lightner Maisashvili Fibbe Lightner LLP
Technical classification
Nice Classes
Class 35Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting on the establishmentmanagementoperation of cancer treatment centers; promoting collaboration within the scientific and medical communities to achieve advances in healthcare; promoting public awareness of cancercancer researchcancer prevention and cancer treatment
Class 44
Medical services; medical servicescellular immunotherapy treatments; medical serviceshuman cancer treatment; providing medical information relating to immunotherapy; providing medical advice and consultancy regarding cancer therapies; medical and pharmaceutical consultation; medical services relating to cancer; dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical servicesthe treatment of cancer; medical consulting servicesconsulting on the treatment of cancer; providing health information in the field of oncologyimmunobiologyimmunotherapydiseases; providing a web site featuring medical and health information; providing medical informationconsultancy and advisory services; providing medical information relating to pharmaceuticals; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical analysis servicesanalysis of tumorscancer and related medical conditions
Class 45
Providing patient advocate services in the treatment of diseases and disorders; providing a website featuring supportive personal stories on the subjects of health and cancer; providing personal support services for patients and families of patients with canceremotional counseling and emotional support
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
05/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/09/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/09/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/09/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/09/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
01/17/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
01/17/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/17/2024
GNRT
NON-FINAL ACTION E-MAILED
10/17/2024
CNRT
NON-FINAL ACTION WRITTEN
10/17/2024
DOCK
ASSIGNED TO EXAMINER
10/15/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2024
NWAP
NEW APPLICATION ENTERED
04/02/2024
Continuous trademark protection
Get notified about every new filing that threatens MD ANDERSON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.